Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1998-01-23
2000-03-07
Campell, Bruce R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
4353201, A61K 4800, C12N 1563
Patent
active
06034072&
ABSTRACT:
Plasmid expression systems for delivery of DNA coding sequences to a mammal are described which provide expression of human IL-2. Also described are particular lipid/DNA delivery systems having advantageous characteristics of size, charge ratio, and proportion of supercoiled DNA, and methods of preparing and using such delivery systems for treatment.
REFERENCES:
patent: 4738927 (1988-04-01), Taniguchi et al.
patent: 4897355 (1990-01-01), Eppstein et al.
patent: 5703055 (1997-12-01), Felgner et al.
patent: 5827703 (1998-10-01), Debs et al.
Anderson, Ed., "Recombinant DNA Advisory Committee (RAC) Data Management Report," Dec., Human Gene Therapy 6:535-548 (1994).
Brinster et al., "Introns Increase Transcriptional Efficiency in Transgenic Mice," Proc. Natl. Acad. Sci. USA, 85:836-840 (1988).
Chen et al., "Bipartite Structure of the Downstream Element of the Mouse Beta Globin (major) Poly(A) Signal," Nucl. Acids Res. 20:2565-2572 (1992).
Choi et al., "A Generic Intron Increases Gene Expression in Transgenic Mice" Mol. Cell Biol. 11:3070-3074 (1991).
Evans et al., "Introns in the 3'-untranslated Region can Inhibit Chimeric CAT and .beta.-galactosidase Gene Expression," Gene 84:135-142 (1989).
Fitzwater et al., "Conditional High Copy No. ColE1 Mutants: Resistance to RNA1 Inhibition in vivo and in vitro," EMBO J 7:3289-3297 (1988).
Gao et al., "Cationic Liposome-mediated Gene Transfer," Gene Therapy 2:710-722 (1995).
Ghersa et al., "Commonly Used cat Reporter Vectors Contain a cAMP-Inducible, Crpytic Enhancer that Co-operates with NF-KB-sites," Gene 151:331-332 (1994).
Gil et al., "A Sequence Downstream of AAUAAA is Required for Rabbit .beta.-globin mRNA 3'-End Formation," Nature 312:473-474 (1984).
Gil et al., Position-dependent Sequence Elements Downstream of AAUAAA are Required for Efficient Rabbit .beta.-Globin mRNA 3' End Formation Cell 49:399-406 (1987).
Hawkins, "A Survey on Intron and Exon Legths," Nucl. Acids Res. 16:9893-9909 (1988).
Hofland et al., "Inhibtion of Human Ovarian Carcinoma Cell Proliferation by Liposome-Plasmid DNA Complex," Biochem. Biophys. Res. Comm. 207:492-496 (1995).
Huang et al., "The Simian Virus 40 Small-t Intron, Present in Many Common Expression Vectors, Leads to Aberrant Splicing," Mol. Cell Biol. 10:1805-1810 (1990).
Jackson et al., "Do the Poly(A) Tail and 3' Untranslated Region Control mRNA Translation?," Cell 62:15-24 (1990).
Kozak, "Determinants of Translational Fidelty and Efficiency in Vertebrate mRNAs," Biochemie 76:815-821 (1994).
Kushner et al., "Eukaryotic Regulatory Elements Lurking in Plasmid DNA: The Activator Protein-1 Site in pUC," Molecular Endocrinology. 8:405-407 (1994).
Leite et al., "Negative Effect of a cis-acting pBR322 Element on Adenovirus E1a Gene Expression," Gene 82:351-356 (1989).
Lusky et al., "Inhbition of SV40 Replication in Simian Cells by Specific pBR322 DNA Sequences," Nature 293:79-81 (1981).
Palmiter et al., "Heterologous Introns can Enhance Expression of Transgenes in Mice," Proc. Natl. Acad. Sci. USA 88:478-482 (1991).
Parker et al., "Plasmid DNA Gene Therapy: Studies with the Human Interleukin-2 Gene in Tumor Cells in vitro and in the Murine B16 Melanoma Model in vivo," Cancer Gene Ther. 3:175-185 (1996).
Peterson et al., "Context-Dependent Gene Expression: cis-Acting Negative Effects of Specific Procaryotic Plasmid Sequences on Eucaryotic Genes," Molecular and Cellular Biology 7:1563-1567 (1987).
Proudfoot, "Poly(A) Signals," Cell 64:671-674 (1991).
Sato et al., "Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization," Science 273:352-354 (1996).
Smith, "Regulatory Considerations for Nucleic Acid Vaccines," Vaccine 12(16):1515-1519 (1994).
Suzuki et al., An Introduction to Genetic Analysis, p. 404 (1989).
Szala et al., "The Use of Cationic Liposomes DC-CHOL/DOPE and DDAB/DOPE for Direct Transfer of Escherichia coli Cytosine Deaminase Gene into Growing Melanoma Tumors," Gene Therapy 3:1026-1031 (1996).
Tully et al., "pBR322 Contains Glucocorticoid Regulatory Element DNA Consensus Sequences," Biochemical and Biophysical Research Communications 144:1-10 (1987).
Uhlin et al., "A Runaway-replication Mutant of Plasmid R1drd-19: Temperature-Dependent Loss of Copy Number Control," Mol. Gen. Genet. 165:167-179 (1978).
Ulfendahl et al., "Splicing of the Adenovirus-2 EIA 13S mRNA Requires a Minimal Intron Length and Specific Intron Signals," Nucl. Acids Res. 13:6299-6315 (1985).
Yamamoto et al., "Lipofection of Synthetic Oligodeoxyribonucleotide having a Palindromic Sequence of AACGTT to Murine Splenocytes Enhances Interferon Production and Natural Killer Activity," Microbiol. Immunol. 38(10):831-836 (1994).
Yoder et al., "Procaryotic Genomic DNA Inhibits Mammalian Cell Transformation," Molecular and Cellular Biology 3:956-959 (1983).
Demolder et al. (1992) Gene, vol. 111, 207-213.
Funk et al. (1990) Biochemistry, vol. 29, 1654-1660.
Mumper et al. (1996) Pharmaceutical Research, vol. 13 (5), 701-709.
Ross et al. (1996) Human Gene Therapy, vol. 7, 1781-1790.
Verma et al. (1997) Nature, vol. 389, 239-242.
Orkin et al. (1995) "Report and Recommendations of the Panel to Assess the NIH Investment in Gene therapy".
Bruno Maria
Muller Susanne
Mumper Russ
Munger William
Ralston Robert
Beckerleg Anne Marie S.
Campell Bruce R.
Genemedicine, Inc.
LandOfFree
IL-2 gene expression and delivery systems and uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IL-2 gene expression and delivery systems and uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IL-2 gene expression and delivery systems and uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-363235